For 60 years, doctors and scientists searched for a vaccine against a common virus that, while sometimes deadly, is little known to the public. The hunt is over.
May 6, 2023
0
26
When scientists were developing a vaccine against COVID-19, a key worry was the potential to cause disease enhancement. It's a complication that occurs when a vaccine does the opposite of what it's intended to do and instead ...
Oct 25, 2021
0
436
Expectant mothers in London are among the first in the world to participate in a clinical trial of a possible vaccine against a virus which causes life threatening breathing problems in babies.
Oct 4, 2017
0
321
US biotech company Moderna on Tuesday announced positive interim trial results for its vaccine against respiratory syncytial virus (RSV) in adults over the age of 60.
Jan 17, 2023
0
20
A team of researchers at the University of Glasgow has found that when placed together in human tissue, the influenza virus A and the respiratory syncytial virus (RSV) can fuse together, forming a hybrid virus. In their paper ...
Masking—along with social distancing, hand washing, and other so-called "non-pharmaceutical interventions" (NPIs)—proved very effective at limiting the spread of COVID-19, and simultaneously drove down rates of endemic ...
Dec 1, 2022
0
76
Pediatricians' offices, children's hospitals, urgent care centers and emergency rooms across the United States are being overwhelmed by an early, heavy surge of respiratory syncytial virus (RSV) among infants and young children.
Oct 25, 2022
0
5
A new analysis of how the immune system responds to both older and newer investigational vaccines for respiratory syncytial virus—RSV—will help inform the ultimate translation of an immunization from the laboratory to ...
Close interactions with infectious disease set both University of California, Santa Cruz graduate student Ana Nuñez Castrejon and Associate Professor of Biomolecular Engineering Rebecca DuBois on the path of studying respiratory ...
Mar 10, 2022
0
85
An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase and inhibits the synthesis of viral genetic material has been identified, a finding that could provide an effective treatment ...
Jun 24, 2022
0
112
